A new deep learning model using histopathology images identifies recurrence risk in stage II colorectal cancer more effectively than standard clinical predictors.
Key Details
- 1Researchers developed a deep learning model (SurvFinder) trained on whole slide histopathology images from stage II colorectal cancer patients.
- 2The study retrospectively analyzed multi-center data from patients in China and the United States.
- 3The AI model identified features associated with risk of recurrence at a higher success rate than traditional clinical prognostic tools.
- 4Study details and results are published in PLOS Medicine, open access.
Why It Matters
Digital pathology AI models can enhance prognostic accuracy and help personalize treatment plans for cancer patients. Outperforming current clinical tools could enable better risk stratification and improved outcomes in stage II colorectal cancer.
Source
EurekAlert
Related News
•EurekAlert
AI Predicts Risks for Outpatient Stem Cell Therapy in Myeloma
Researchers use machine learning to predict adverse events during stem cell therapy for multiple myeloma, improving outpatient safety.
•EurekAlert
AI-Enhanced CT Heart Fat Measurement Boosts Cardiovascular Risk Prediction
AI-derived measurement of heart fat from CT scans significantly improves long-term cardiovascular disease risk prediction.
•EurekAlert
Interpretable Machine Learning Model Predicts ICU Sepsis Mortality Risk
Researchers have developed and validated a machine learning tool to predict 28-day mortality in ICU patients with sepsis and acute respiratory failure using early clinical data.